Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Louis

Showing results (81-90 of 290) with videos related to

Pageof 29
Sort By:
Gastroenterology|September 19, 2015
Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel DiseaseJoana Torres, Ray K Boyapati, Nicholas A Kennedy, et al.
Clinics and Research in Hepatology and Gastroenterology|January 28, 2026
QuantiFERON-Monitor as Prognostic Marker of Mortality in Patients with Decompensated Cirrhosis: a Prospective Cohort StudyAlice Dongier, Edouard Louis, Jean-Philippe Loly, et al.
The Lancet. Healthy Longevity|September 13, 2022
Is it time to include older adults in inflammatory bowel disease trials? A call for actionSophie Vieujean, Bénédicte Caron, Vipul Jairath, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 14, 2011
Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: a meta-analysisDavid G Binion, Edouard Louis, Bas Oldenburg, et al.
European Journal of Gastroenterology & Hepatology|April 16, 2002
Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resourcesEdouard Louis, Danny DeLooze, Pierre Deprez, et al.
Expert Opinion on Pharmacotherapy|July 4, 2023
Stemming the tide with ileocecal Crohn's disease: when is pharmacotherapy enough?Sophie Vieujean, Paulo Gustavo Kotze, Patrick Netter, et al.
Inflammatory Bowel Diseases|April 8, 2011
Natalizumab to kill two birds with one stone: a case of celiac disease and multiple sclerosisRémy Phan-Ba, Nadine Lambinet, Edouard Louis, et al.
Revue Medicale De Liege|February 14, 2025
[MR Imaging of ano-perineal fistulas]Paul Meunier, Catherine Reenaers, Catherine Van Kemseke, et al.
Advances in Therapy|March 23, 2021
Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn's DiseaseLaurent Peyrin-Biroulet, Edouard Louis, Edward V Loftus, et al.
Inflammatory Bowel Diseases|April 12, 2023
In-Depth Assessment of Endoscopic Remission in Inflammatory Bowel Disease Treated by Anti-TNF or VedolizumabJean-Philippe Loly, Sophie Vieujean, Catherine Reenaers, et al.
Pageof 29

Showing results (81-90 of 290) with videos related to

Sort By:
Pageof 29
Gastroenterology|September 19, 2015
Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel DiseaseJoana Torres, Ray K Boyapati, Nicholas A Kennedy, et al.
Clinics and Research in Hepatology and Gastroenterology|January 28, 2026
QuantiFERON-Monitor as Prognostic Marker of Mortality in Patients with Decompensated Cirrhosis: a Prospective Cohort StudyAlice Dongier, Edouard Louis, Jean-Philippe Loly, et al.
The Lancet. Healthy Longevity|September 13, 2022
Is it time to include older adults in inflammatory bowel disease trials? A call for actionSophie Vieujean, Bénédicte Caron, Vipul Jairath, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 14, 2011
Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: a meta-analysisDavid G Binion, Edouard Louis, Bas Oldenburg, et al.
European Journal of Gastroenterology & Hepatology|April 16, 2002
Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resourcesEdouard Louis, Danny DeLooze, Pierre Deprez, et al.
Expert Opinion on Pharmacotherapy|July 4, 2023
Stemming the tide with ileocecal Crohn's disease: when is pharmacotherapy enough?Sophie Vieujean, Paulo Gustavo Kotze, Patrick Netter, et al.
Inflammatory Bowel Diseases|April 8, 2011
Natalizumab to kill two birds with one stone: a case of celiac disease and multiple sclerosisRémy Phan-Ba, Nadine Lambinet, Edouard Louis, et al.
Revue Medicale De Liege|February 14, 2025
[MR Imaging of ano-perineal fistulas]Paul Meunier, Catherine Reenaers, Catherine Van Kemseke, et al.
Advances in Therapy|March 23, 2021
Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn's DiseaseLaurent Peyrin-Biroulet, Edouard Louis, Edward V Loftus, et al.
Inflammatory Bowel Diseases|April 12, 2023
In-Depth Assessment of Endoscopic Remission in Inflammatory Bowel Disease Treated by Anti-TNF or VedolizumabJean-Philippe Loly, Sophie Vieujean, Catherine Reenaers, et al.
Pageof 29